Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

Live Webinar: COVID-19 Has Changed Live Events Forever!

We invite you to join Impetus Digital and the Medical Affairs Professional Society (MAPS) on February 19, 10 am EST, for a thought-provoking webinar around the future of virtual events.

Impetus Digital

- PMLiVE

Amgen strikes $240m autoimmune deal with Evoq Therapeutics

Companies will collaborate on novel drugs for autoimmune disorders

- PMLiVE

Lucid Group bolster its talent with a further twelve new starters for 2021

As if welcoming eight new graduates was not enough to bring some excitement to the start of the new year, Lucid Group has also welcomed a further twelve new employees...

Lucid Group Communications Limited

- PMLiVE

PHE study finds people who have had COVID-19 can still transmit the virus

Protection after infection lasts for at least five months on average

- PMLiVE

UK pharmacies to begin administering COVID-19 vaccinations

Pharmacies will join the effort to bolster the UK’s mass vaccination rollout

- PMLiVE

New dosing option for AZ’s Imfinzi approved in the EU and UK

Additional option extends dosing from two weeks to four weeks

- PMLiVE

New executive appointments at Synergy Vision

Eileen Gallagher and Karine Henderson take on new leadership roles

- PMLiVE

2021: the year of decentralisation in drug development

By Marie McCarthy

Health IT and Clinical Informatics for Improving Patient Care

Dr. Donald Rucker, National Coordinator at the Office of the National Coordinator for Health Information Technology (ONC Health IT), explores all things medical and clinical informatics and “Health IT.” Among other...

Impetus Digital

Bayer symbol

Bayer’s finerenone scores FDA priority review for chronic kidney disease

FDA priority review is based on data from the phase 3 FIDELIO-DKD trial

- PMLiVE

Takeda and KSQ Therapeutics to develop immune-based cancer treatments

Collaboration will utilise KSQ’s CRISPR-screening technology

- PMLiVE

Celltrion’s investigational mAb cuts COVID-19 recovery time

Patients treated with mAb recovered 3.4 to 6.4 days quicker compared to placebo

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links